SCHEMBL9429162

SCHEMBL9429162

CC=CC(=O)N(c1ccc(-c2cccc(OC)c2)s1)C1CCNC1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.41
HSD17B2 P37059 11/20 0.40
HSD17B1 P14061 9/20 0.40
MCHR1 Q99705 1/20 0.39
CHEK1 O14757 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.37
MC4R P32245 1/20 0.36
CNR1 P21554 1/20 0.36
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429644 0.91 APP (0.37) HSD17B2HSD17B1MCHR1CHEK1TRPM8
SCHEMBL9428841 0.88 HSD17B1 (0.38) HSD17B2HSD17B1TRPM8CNR1CYP2D6
SCHEMBL9429101 0.87 CHRM1 (0.42) HSD17B2HSD17B1MCHR1CHEK1CYP2D6
SCHEMBL9429798 0.83 CDK2AP1 (0.35) HSD17B2HSD17B1MCHR1CHEK1TRPM8
SCHEMBL9429417 0.83 ERCC5 (0.39) MCHR1CHEK1SLC6A2SLC6A4SLC6A3
SCHEMBL9429749 0.83 EP300 (0.35) MCHR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9428532 0.83 MCHR1 (0.40) MCHR1CHEK1SLC6A2SLC6A4SLC6A3
SCHEMBL9429795 0.82 SLC6A4 (0.34) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL9429984 0.82 SLC6A4 (0.39) MCHR1CHEK1CYP2D6SLC6A2SLC6A4
SCHEMBL9428834 0.82 SLC6A4 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328907-A Treatment of allograft rejection in mammals and antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1994-07-12 US disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed